PDL BioPharma Inc (NASDAQ:PDLI)

2.48
Delayed Data
As of Feb 23
 -0.02 / -0.80%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-10.3M7.2M60.4M20.7M
 
 
 
 
 
Depreciation6.0M6.0M6.1M6.3M
 
 
 
 
 
Total Other Cash Flow28.7M-7.9M-78.3M-34.0M
 
 
 
 
 
Funds From Operations19.8M20.6M2.2M-7.3M
 
 
 
 
 
Funds From/For Other Operating Expenses4.1M-25.1M-13.6M-5.1M
 
 
 
 
 
Net Cash Flow - Operating Activities15.7M45.8M15.8M-2.1M
 
 
 
 
 
 
InvestingIncrease In Investments-15.0M-16.0M-3.9M-4.8M
 
 
 
 
 
Decrease In Investments3.0M16.0M13.0M83.9M
 
 
 
 
 
Capital Expenditures-25.0K-534.0K-171.0K-455.0K
 
 
 
 
 
Fixed Asset Disposal250.0K----0.00
 
 
Net Assets From Acquisitions 0.000.000.00-2.2M
 
 
Other Investing - Uses-1.0M0.000.000.00
 
 
Other Investing - Sources25.3M129.6M34.8M171.2M
 
 
 
 
 
Net Cash Flow Investing12.6M129.1M43.8M247.6M
 
 
 
 
 
 
FinancingShort Term Borrowings25.0M0.000.000.00
 
 
Long Term Borrowings147.1M------
 
 
Long Term Debt Reduction-25.0M------
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-120.0M-7.6M-22.4M0.00
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-150.0K-21.0K0.000.00
 
 
 
Other Sources - Financing--0.00------
Other Uses - Financing14.4M0.002.2M84.8M
 
 
 
 
Net Cash Flow - Financing12.3M-7.7M-24.5M-84.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash40.6M167.2M35.1M160.7M